- Home
- WLKP vs IMNM Comparison
WLKP vs IMNM Comparison
Compare WLKP & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLKP
- IMNM
- Stock Information
- Founded
- WLKP 2014
- IMNM 2006
- Country
- WLKP United States
- IMNM United States
- Employees
- WLKP N/A
- IMNM N/A
- Industry
- WLKP Major Chemicals
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- WLKP Industrials
- IMNM Health Care
- Exchange
- WLKP Nasdaq
- IMNM Nasdaq
- Market Cap
- WLKP 795.0M
- IMNM 945.8M
- IPO Year
- WLKP 2014
- IMNM 2020
- Fundamental
- Price
- WLKP $22.00
- IMNM $10.28
- Analyst Decision
- WLKP
- IMNM Strong Buy
- Analyst Count
- WLKP 0
- IMNM 6
- Target Price
- WLKP N/A
- IMNM $25.67
- AVG Volume (30 Days)
- WLKP 36.0K
- IMNM 664.7K
- Earning Date
- WLKP 08-05-2025
- IMNM 08-06-2025
- Dividend Yield
- WLKP 8.57%
- IMNM N/A
- EPS Growth
- WLKP N/A
- IMNM N/A
- EPS
- WLKP 1.49
- IMNM N/A
- Revenue
- WLKP $1,101,803,000.00
- IMNM $12,589,000.00
- Revenue This Year
- WLKP $8.90
- IMNM N/A
- Revenue Next Year
- WLKP $6.87
- IMNM $259.34
- P/E Ratio
- WLKP $14.73
- IMNM N/A
- Revenue Growth
- WLKP N/A
- IMNM 16.74
- 52 Week Low
- WLKP $21.19
- IMNM $5.15
- 52 Week High
- WLKP $25.04
- IMNM $16.73
- Technical
- Relative Strength Index (RSI)
- WLKP 48.11
- IMNM 53.58
- Support Level
- WLKP $21.77
- IMNM $9.81
- Resistance Level
- WLKP $22.40
- IMNM $10.38
- Average True Range (ATR)
- WLKP 0.25
- IMNM 0.51
- MACD
- WLKP 0.01
- IMNM -0.12
- Stochastic Oscillator
- WLKP 38.46
- IMNM 48.80
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.